Corporate
Lilly Proves Zepbound Boosts Psoriasis Treatment: GLP-1s Expand Beyond Weight Loss
Feb 20
You're signed outSign in or to get full access.
Leadership at ELI LILLY &
Browse executives, board members, and key leadership.
Executives at ELI LILLY &
Board Members at ELI LILLY &
Recent News about ELI LILLY &
Deals & Capital Markets
Eli Lilly Pays Up to $2.4 Billion for Orna Therapeutics, Joining In Vivo CAR-T Race
Feb 9
Deals & Capital Markets
Eli Lilly Deepens China Bet with $8.85B Innovent Oncology and Immunology Deal
Feb 9
Policy & Geopolitics
TrumpRx Goes Live: GLP-1 Drug Prices Slashed Up to 85%, Pharma Stocks React
Feb 6
Corporate
Eli Lilly Crushes Q4 as Mounjaro and Zepbound Sales Double—Stock Surges 8%
Feb 4
Corporate
Eli Lilly Bets $3.5 Billion on Pennsylvania to Build Retatrutide Arsenal
Jan 30